Holmes, 40, a Stanford University dropout, was charged in 2018 in connection with $878 million in losses among investors in ...
Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results